EDGAR Filing Documents for 0001104659-15-054656

Form 8-K - Current report:

SEC Accession No. 0001104659-15-054656

Filing Date

2015-07-30

Accepted

2015-07-30 08:00:46

Documents

Period of Report

2015-04-30

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a15-16582_18k.htm	8-K	20487
2	EX-99.1	a15-16582_1ex99d1.htm	EX-99.1	262804
3	GRAPHIC	g165821mm01i001.gif	GRAPHIC	3895
	Complete submission text file	0001104659-15-054656.txt		290096

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 151014439
SIC: 2834 Pharmaceutical Preparations